Zobrazeno 1 - 9 of 9 pro vyhledávání: '"S. Zhabrov"'
1
Akademický článek
Real-world effectiveness and safety of pan-genotypic antiviral therapy for chronic HCV-infection: data from three clinical centers in St. Petersburg
Autor: D. A. Gusev, K. V. Zhdanov, K. V. Kozlov, T. N. Vinogradova, M. Yu. Kopot, V. S. Sukachev, S. S. Zhabrov, S. N. Kizhlo, S. Yu. Romanova, V. B. Musatov, N. V. Tyurenkova, Yu. A. Vlasova, E. Yu. Kolpashchikova, P. N. Fedorov, P. V. Minin, T. S. Korneeva
Publikováno v: Журнал инфектологии, Vol 14, Iss 5, Pp 60-68 (2023)
The aim of the analysis was to describe the results of administration of pan-genotype antiviral therapy (glecaprevir / pibrentasvir, GLE / PIB) in real-world setting in three clinical centers in St. Petersburg within the city program for the treatmen
Externí odkaz: https://doaj.org/article/6bca810fbc6e4594b9f661b807d84ac9
Zobrazit plný text záznamu
2
Akademický článek
Non-invasive diagnosis of fibrosis in patients with CHC and obesity
Autor: K. V. Zhdanov, M. V. Yaremenko, K. V. Kozlov, S. S. Zhabrov, V. S. Sukachev, D. Yu. Lobzin, D. M. Shakhmanov, D. V. Laurenchuk, S. S. Karyakin, A. V. Saulevich, I. V Potehin, K. P. Plotnikov
Publikováno v: Журнал инфектологии, Vol 12, Iss 1, Pp 40-47 (2020)
The aim of the study was to assess the possibilities of noninvasive diagnosis of liver fibrosis (FIB-4 and APRI indices) in patients with CHC and abdominal obesity.Materials and methods. 52 men with CHC were examined. Genotype 1 was determined in 24
Externí odkaz: https://doaj.org/article/b32697eb7b57489e8b21b50af645b736
Zobrazit plný text záznamu
3
Possibilities of antifibrotic therapy and correction of cognitive disorders in experimentally induced severe liver fibrosis and cirrhosis in rats
Autor: Maksim G. Chernenok, Andrey V. Saulevich, Konstantin V. Zhdanov, Yuriy F. Zakharkiv, Konstantin V. Kozlov, Vitaliy S. Sukachev, Sergey M. Zakharenko, Ruslan M. Mukhtarov, Vadim E. Karev, Timofey V. Gavrilyuk, Konstantin S. Ivanov, Yuriy I. Lyashenko, Sergey S. Zhabrov
Publikováno v: Russian Military Medical Academy Reports. 41:203-216
BACKGROUND: The main pathogenetic aspects of the correction of cognitive impairment of the brain and antifibrotic therapy against the background of experimentally induced severe fibrosis and cirrhosis of the liver in rats are considered. Viral hepati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f106a270dd05edf281ff3f4f7fa1f16
https://doi.org/10.17816/rmmar104663
Zobrazit plný text záznamu
4
Akademický článek
Virological and morphological relationships in the phases of the immune control and reactivation in patients with chronic hepatitis B
Autor: I. A. Gabdrakhmanov, A. V. Semenov, Yu. V. Ostankova, K. V. Kozlov, K. V. Zhdanov, D. A. Gusev, V. S. Sukachev, D. M. Shakhmanov, S. S. Zhabrov, A. S. Peremyshlenko, Yu. I. Bulankov, A. M. Ivanov, A. A. Totolian
Publikováno v: Журнал инфектологии, Vol 7, Iss 4, Pp 37-43 (2016)
Objective: To evaluate relationships between virological and morphological data in patients with chronic hepatitis B in phase immune control and reactivation.Materials and methods: The study involved 46 patients with chronic hepatitis B, indicators d
Externí odkaz: https://doaj.org/article/1046e5c0753d429fb566cde7821b87e9
Zobrazit plný text záznamu
6
Akademický článek
Relationship between gene polymorphism of IL-28B and clinical, laboratory, virologic parameters in patients with chronic HCV-infection
Autor: K. V. Zhdanov, D. A. Gusev, K. V. Kozlov, V. S. Sukachyov, A. V. Shekurov, S. S. Zhabrov, D. M. Shakhmanov, D. V. Berg, K. S. Ivanov, Yu. I. Lyashenko, T. M. Zubik
Publikováno v: Журнал инфектологии, Vol 6, Iss 4, Pp 19-26 (2014)
For the purpose of clinical laboratory and virologic characteristics of chronic HCV-infection, depending on the gene polymorphisms of IL-28B were examined 104patients. In 70 patients (50 – with genotype 1 and 20 – with genotypes 2 and 3) treated
Externí odkaz: https://doaj.org/article/8a88254c131149d1914ee94df552979f
Zobrazit plný text záznamu
7
Akademický článek
HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
Autor: K. V. Zhdanov, D. A. Gusev, K. V. Kozlov, S. S. Zhabrov, A. V. Shekurov, A. V. Nagovitsyn, A. V. Mishin, E. V. Jakovleva
Publikováno v: Журнал инфектологии, Vol 6, Iss 2, Pp 83-86 (2014)
Presented clinical case describes elimination followed by seroconversion HBsAg / HBsAb patient with HBeAg-negative chronic hepatitis B on antiviral therapy with pegylated interferon α2-a and achieving sustained virological response.
Externí odkaz: https://doaj.org/article/adbfed1257e64d9a9f098fcd9bea513a
Zobrazit plný text záznamu
8
[Effectiveness and safety of antiviral therapy of military personnel suffering from chronic hepatitis C]
Autor: K V, Zhdanov, D A, Gusev, K V, Kozlov, M K, Shishkin, V S, Sukachev, D M, Shakhmanov, S S, Zhabrov
Publikováno v: Voenno-meditsinskii zhurnal. 336(4)
In order to evaluate effectiveness and safety of antiviral therapy schemes examined and treated 191 patients with chronic bepatitis C were assigned standard interferon and ribavirin, pegslated interferon and ribavirin, the total duration of the cours
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::119839220bd792b3da0e447867492023
https://pubmed.ncbi.nlm.nih.gov/26454938
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje